Black Rock Inc. Amneal Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,282,430 shares of AMRX stock, worth $102 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,282,430
Previous 9,164,172
23.11%
Holding current value
$102 Million
Previous $55.5 Million
29.01%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
183Shares Held
141MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$197 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$132 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million1.95% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.8 Million2.48% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il9.99MShares$90.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.37B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...